您的位置: 首页 > 农业专利 > 详情页

prostate cancer treatment
专利权人:
Inc.;Tokai Pharmaceuticals
发明人:
Cy Aaron Stein,David Scott Casebier,Jodie Pope Morrison
申请号:
BR112012002797
公开号:
BR112012002797A2
申请日:
2010.08.05
申请国别(地区):
BR
年份:
2019
代理人:
摘要:
Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. Such compounds include inhibitors of cytochrome C17α-hydroxylase/C17,20-lyase such as 3-&bgr;-Hydroxy-17-(1H-benzimidazol-1-yl)androsta-5,16-diene.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充